Michael Sontag
Analyst
Leerink Partners
Equibles does not estimate personal net worth.
About Michael Sontag
Michael Sontag is recorded as Analyst at Leerink Partners. Michael Sontag has spoken on 1 earnings call across 1 company, most recently for Nautilus Biotechnology, Inc. on October 27, 2026. The companies whose calls Michael Sontag spoke on are classified in the Healthcare sector.
Michael Sontag on recent calls
“I think first I was wondering if you could offer any details on some of the use cases you're seeing from the early access TAL work you're doing.”
Affiliation history
-
Leerink Partners
Analyst
Transcript header (unverified)
Current